Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $2.48 billion. The enterprise value is $2.16 billion.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IOVA has 304.78 million shares outstanding. The number of shares has increased by 30.80% in one year.
| Current Share Class | 304.78M |
| Shares Outstanding | 304.78M |
| Shares Change (YoY) | +30.80% |
| Shares Change (QoQ) | +6.48% |
| Owned by Insiders (%) | 9.58% |
| Owned by Institutions (%) | 62.53% |
| Float | 224.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.88 |
| Forward PS | 5.50 |
| PB Ratio | 3.21 |
| P/TBV Ratio | 5.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 23.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.10.
| Current Ratio | 4.22 |
| Quick Ratio | 3.84 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.65% and return on invested capital (ROIC) is -33.47%.
| Return on Equity (ROE) | -56.65% |
| Return on Assets (ROA) | -29.15% |
| Return on Capital (ROIC) | -33.47% |
| Revenue Per Employee | $163,120 |
| Profits Per Employee | -$736,081 |
| Employee Count | 557 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 3.47 |
Taxes
| Income Tax | -6.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.19% in the last 52 weeks. The beta is 0.59, so IOVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +61.19% |
| 50-Day Moving Average | 9.97 |
| 200-Day Moving Average | 10.78 |
| Relative Strength Index (RSI) | 33.64 |
| Average Volume (20 Days) | 8,833,607 |
Short Selling Information
The latest short interest is 59.73 million, so 19.60% of the outstanding shares have been sold short.
| Short Interest | 59.73M |
| Short Previous Month | 60.34M |
| Short % of Shares Out | 19.60% |
| Short % of Float | 26.55% |
| Short Ratio (days to cover) | 13.08 |
Income Statement
In the last 12 months, IOVA had revenue of $90.86 million and -$410.00 million in losses. Loss per share was -$1.48.
| Revenue | 90.86M |
| Gross Profit | 8.04M |
| Operating Income | -429.96M |
| Pretax Income | -446.08M |
| Net Income | -410.00M |
| EBITDA | -408.32M |
| EBIT | -429.96M |
| Loss Per Share | -$1.48 |
Full Income StatementBalance Sheet
The company has $397.49 million in cash and $78.94 million in debt, giving a net cash position of $318.55 million or $1.05 per share.
| Cash & Cash Equivalents | 397.49M |
| Total Debt | 78.94M |
| Net Cash | 318.55M |
| Net Cash Per Share | $1.05 |
| Equity (Book Value) | 773.46M |
| Book Value Per Share | 2.54 |
| Working Capital | 380.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$363.65 million and capital expenditures -$10.43 million, giving a free cash flow of -$374.08 million.
| Operating Cash Flow | -363.65M |
| Capital Expenditures | -10.43M |
| Free Cash Flow | -374.08M |
| FCF Per Share | -$1.23 |
Full Cash Flow StatementMargins
| Gross Margin | 8.85% |
| Operating Margin | -473.22% |
| Pretax Margin | -458.01% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -1,222.02% |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.80% |
| Shareholder Yield | -30.80% |
| Earnings Yield | -16.53% |
| FCF Yield | -15.08% |
Dividend DetailsAnalyst Forecast
The average price target for IOVA is $23.33, which is 186.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.33 |
| Price Target Difference | 186.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 311.39% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 0.01:1.
| Last Split Date | Sep 26, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.01:1 |
Scores
IOVA has an Altman Z-Score of 2.92 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.92 |
| Piotroski F-Score | 4 |